ASCO 2021: Updates in Myeloproliferative Neoplasms
This publication covers a multitude of presentations in myeloproliferative neoplasms that were presented and discussed during the 2021 ASCO Annual Meeting.
Volume: 1
Issue: 1
ASCO 2021: Updates in Genitourinary Cancers
This publication provides coverage of data in genitourinary cancers that were presented at the 2021 ASCO Annual Meeting.
My Treatment Approach: Lung Cancer Practice Patterns
The Evolving Role of Immunotherapy in Metastatic Non–Small Cell Lung Cancer
2021 EBMT Annual Meeting
Coverage of the 2021 EBMT Annual Meeting, held virtually March 14-17, 2021.
Defining Value for the Treatment of Brain Metastases in Metastatic HER2-Positive Breast Cancer
Volume: 01
Issue: 01
2021 Genitourinary Cancers Symposium
Volume: 02
2021 Gastrointestinal Cancers Symposium
Updates in NRG1+ Tumors
My Treatment Approach: BRAF+ Melanoma
ASH 2020: CAR T-Cell Therapy Updates
Frontline Immunotherapy Updates in Advanced NSCLC
Year in Review: HER2+ Updates in Oncology
Updates in Relapsed/Refractory AML
Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 2
Issue: 2
Therapeutic Considerations in Metastatic HER2+ Breast Cancer: Part 1
SABCS 2020: Reflections in HER2+ Breast Cancer
Current and Emerging Trends in Chronic Myeloid Leukemia
Updates and Advances in Basal Cell Carcinoma
Volume: 2
My Treatment Approach: Locally Advanced Lung Cancer
Utilizing Tumor Metabolism in Solid Malignancies
Updates in ESR1-Mutant Breast Cancer
My Treatment Approach: Multiple Myeloma
My Treatment Approach: Chronic Lymphocytic Leukemia
Advances in Immunotherapy in Metastatic Non–Small Cell Lung Cancer
Role of Trop-2 as an Actionable Biomarker in Solid Tumors
The Role of Chemotherapy and Novel Combinations in Triple Negative Breast Cancer
ESMO 2020 Congress: Focus in Genitourinary Cancers
Updates and New Targets in NSCLC: An OncLive® Scientific Interchange and Workshop
2020 EBMT Meeting Reporter
Time to Bladder Cancer Treatment Is Similar Among Black and White Patients, But Other Disparities Persist
Dr Jia on the Evolving Role of Metastasis-Directed Radiotherapy in Prostate Cancer
Dr Wang on the Limited Utility of Quantitative Molecular Imaging Thresholds in RCC
Darolutamide Use Is Routine in Both Doublets and Triplet Therapies in mHSPC